Lineage Cell Therapeutics, Inc. (LCTX) analyst actions
Rating and price-target actions on LCTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LCTX overview →
2 measured LCTX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes | Press release | -0.20% | -0.80% | |
| Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury | Press release | -2.46% | -1.86% |
Keep exploring
More LCTX: earnings → · SEC filings → · LCTX overview →